Literature DB >> 20577866

Anterior ischemic optic neuropathy following intravitreal bevacizumab.

Jane Y Huang, Hiroaki Ozaki, Hideyuki Hayashi, Eiichi Uchio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20577866     DOI： 10.1007/s10384-009-0790-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Authors:  Eun Jee Chung; Mi In Roh; Oh Woong Kwon; Hyoung Jun Koh
Journal:  Retina       Date:  2008 Jul-Aug       Impact factor: 4.256

2.  Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema.

Authors:  Eric Chen; Jason Hsu; Carl H Park
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Jan-Feb

3.  Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Authors:  Daniel Kook; Atmin Wolf; Thomas Kreutzer; Aljoscha Neubauer; Rupert Strauss; Michael Ulbig; Anslem Kampik; Christos Haritoglou
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

4.  Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

Authors:  Martin Ganssauge; Helmut Wilhelm; Karl-Ulrich Bartz-Schmidt; Sabine Aisenbrey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 3.117

5.  Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.

Authors:  Masahiko Shimura; Toru Nakazawa; Kanako Yasuda; Takashi Shiono; Tomohiro Iida; Taiji Sakamoto; Kohji Nishida
Journal:  Am J Ophthalmol       Date:  2008-03-06       Impact factor: 5.258
  5 in total
  6 in total

1.  Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial.

Authors:  D B Rootman; H S Gill; E A Margolin
Journal:  Eye (Lond)       Date:  2013-02-01       Impact factor: 3.775

2.  Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors:  Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal:  Clin Ophthalmol       Date:  2012-03-06

3.  Single intravitreal aflibercept injection for unilateral acute nonarteritic ischemic optic neuropathy.

Authors:  Ziya Ayhan; Gamze Kocaoğlu; Aylin Yaman; Meltem Söylev Bajin; A Osman Saatci
Journal:  Case Rep Ophthalmol Med       Date:  2015-01-08

4.  Efficacy of intravitreal ranibizumab injection in acute nonarteritic ischemic optic neuropathy: a long-term follow up.

Authors:  Ali Osman Saatci; Okan Taskin; Ozlem Barut Selver; Aylin Yaman; Meltem Soylev Bajin
Journal:  Open Ophthalmol J       Date:  2013-09-30

Review 5.  Translational Preclinical Research may Lead to Improved Medical Management of Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  James D Nicholson; Hana Leiba; Nitza Goldenberg-Cohen
Journal:  Front Neurol       Date:  2014-07-11       Impact factor: 4.003

6.  Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy.

Authors:  Yu-Yen Chen; Pesus Chou; Yu-Fang Huang; Hung-Jen Chien; Yu-Chieh Wu; Chia-Chi Lee; Li-Ying Huang; Hsin-Hua Chen
Journal:  BMC Ophthalmol       Date:  2019-12-30       Impact factor: 2.209
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.